<html><head></head><body><h1>Sumycin Tablets</h1><p class="drug-subtitle"><b>Generic Name:</b> tetracycline hydrochloride<br/>
<b>Dosage Form:</b> tablet, film coated<br/></p><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li>Overview</li>
<li>Side Effects</li>
<li>Dosage</li>
<li>Professional</li>
<li>Interactions</li>
<li class="nav-more">
More&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewBox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/body&gt;&lt;/html&gt;
</li>
</ul><ul>
<li>Description</li>
<li>Clinical Pharmacology</li>
<li>Indications and Usage</li>
<li>Contraindications</li>
<li>Warnings</li>
<li>Precautions</li>
<li>Patient Counseling Information</li>
<li class="ddc-toggle-hidden">Drug Interactions</li>
<li class="ddc-toggle-hidden">Adverse Reactions/Side Effects</li>
<li class="ddc-toggle-hidden">Overdosage</li>
<li class="ddc-toggle-hidden">Dosage and Administration</li>
<li class="ddc-toggle-hidden">Use In Specific Populations</li>
<li class="ddc-toggle-hidden">How Supplied/Storage and Handling</li>
<li class="ddc-toggle-hidden">References</li>
</ul><p>The Sumycin brand name has been discontinued in the U.S. If generic versions of this product have been approved by the FDA, there may be generic equivalents available.</p><h2>Sumycin Tablets Description</h2><p class="First">Tetracycline is a yellow, crystalline powder. Tetracycline is soluble in water, slightly soluble in ethanol (96%), practically insoluble in acetone. It dissolves in solutions of alkali hydroxides and carbonates. Solutions in water become turbid on standing, owing to the precipitation of tetracycline. The  chemical  name  for  tetracycline  hydrochloride  is  4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a­octahydro-3,6,10,12,-12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecar-boxamide monohydrochloride. Its structural formula is as follows:</p><p>Each tablet, for oral administration, contains 250 mg or 500 mg tetracycline hydrochloride.</p><p><span class="Bold">Inactive Ingredients:</span> anhydrous lactose, magnesium stearate, microcrystalline cellulose, povidone, pregelatinized starch and stearic acid. The film coating for the 250 mg and 500 mg are made of D&amp;C RED # 30 / helendon pink aluminium lake, hypromellose and titanium dioxide.</p><p>In addition to these, the 250 mg tablet film coating includes triacetin and 500 mg tablet film coating includes polyethylene glycol.</p><h2>Sumycin Tablets - Clinical Pharmacology</h2><p class="First">Tetracyclines are readily absorbed and are bound to plasma protein in varying degrees. They are concentrated by the liver in the bile and excreted in the urine and feces at high concentrations in a biologically active form.</p><p><span class="Bold">Microbiology</span></p><p>Tetracyclines are primarily bacteriostatic and exert their antimicrobial effect by the inhibition of protein synthesis by binding to the 30S ribosomal subunit. Tetracycline is active against a broad range of gram-negative and gram-positive organisms. The drugs in the tetracycline class have closely similar antimicrobial spectra, and cross-resistance among them is common.</p><p>Tetracycline has been shown to be active against most isolates of the following bacteria, both <span class="Italics">in vitro</span> and in clinical infections as described in the <span class="Bold">INDICATIONS AND USAGE</span> section of the package insert.</p><p><span class="Bold">G</span><span class="Bold">ram-</span><span class="Bold">negative</span><span class="Bold">B</span><span class="Bold">acteria</span></p><p><span class="Bold"> </span></p><p><span class="Italics">Acinetobacter</span> species</p><p><span class="Italics">Bartonella bacilliformis</span></p><p><span class="Italics">Brucella</span> species</p><p><span class="Italics">C</span><span class="Italics">ampylobacter fetus</span></p><p><span class="Italics">Enterobacter aerogenes</span></p><p><span class="Italics">Escherichia coli</span></p><p><span class="Italics">Francisella tularensis</span></p><p><span class="Italics">Haemophilus ducreyi</span></p><p><span class="Italics">Haemophilus influenzae</span></p><p><span class="Italics">Klebsiella</span> species</p><p><span class="Italics">K</span><span class="Italics">l</span><span class="Italics">ebsiella granulomatis</span></p><p><span class="Italics">N</span><span class="Italics">eisseria gonorrhoeae</span></p><p><span class="Italics">Shigella</span> species</p><p><span class="Italics">Vibrio cholerae</span></p><p><span class="Italics">Y</span><span class="Italics">e</span><span class="Italics">rsinia pestis</span></p><p><span class="Bold"> </span></p><p><span class="Bold">G</span><span class="Bold">ram-positive Bacteria</span></p><p><span class="Bold"> </span></p><p><span class="Italics">Bacillus anthracis</span></p><p><span class="Italics">Streptococcus pyogenes</span></p><p><span class="Italics">Streptococcus pneumoniae</span></p><p><span class="Italics">Staphylococcus aureus</span></p><p><span class="Italics">Listeria monocytogenes</span></p><p><span class="Bold"> </span></p><p><span class="Bold">A</span><span class="Bold">naerobes</span></p><p><span class="Bold"> </span></p><p><span class="Italics">Bacteroides</span> species</p><p><span class="Italics">C</span><span class="Italics">l</span><span class="Italics">ostridium</span> species</p><p><span class="Italics">Fusobacterium fusiforme</span></p><p><span class="Italics">Propionibacterium acnes</span></p><p><span class="Italics"> </span></p><p><span class="Bold">Ot</span><span class="Bold">her Bacteria</span></p><p><span class="Bold"> </span></p><p><span class="Italics">Actinomyces</span> species</p><p><span class="Italics">Borrelia recurrentis</span></p><p><span class="Italics">C</span><span class="Italics">hlamydophila psittaci</span></p><p><span class="Italics">C</span><span class="Italics">hlamydia trachomatis</span></p><p><span class="Italics">Rickettsiae</span></p><p><span class="Italics">Treponema pallidum</span></p><p><span class="Italics">Treponema pallidum</span> subspecies <span class="Italics">pertenue</span></p><p><span class="Italics"> </span></p><p><span class="Bold">P</span><span class="Bold">arasites</span></p><p><span class="Bold"> </span></p><p><span class="Italics">Entamoeba</span> species</p><p><span class="Italics">Balantidium coli</span></p><p><span class="Italics"> </span></p><p><span class="Bold">Susceptibility Test Methods</span></p><p><span class="Bold"> </span></p><p>When available, the clinical microbiology laboratory should provide the results of <span class="Italics">in vitro</span> susceptibility test results for antimicrobial drugs used in resident hospitals to the physician as periodic reports that describe the susceptibility profile of nosocomial and community-acquired pathogens. These reports should aid the physician in selecting the most effective antimicrobial.</p><p><span class="Bold"> </span></p><p><span class="Bold">D</span><span class="Bold">il</span><span class="Bold">ution Techniques</span></p><p><span class="Bold"> </span></p><p>Quantitative methods are used to determine antimicrobial minimum inhibitory concentrations (MICs). These MICs provide estimates of the susceptibility of bacteria to antimicrobial compounds. The MICs should be determined using a standardized test method<span class="Sup">1,2,4</span> (broth and/or agar). The MIC values should be interpreted according to the criteria provided in Table 1.</p><p><span class="Bold"> </span></p><p><span class="Bold">Di</span><span class="Bold">f</span><span class="Bold">f</span><span class="Bold">u</span><span class="Bold">sion Techniques</span></p><p><span class="Bold"> </span></p><p>Quantitative methods that require measurement of zone diameters can also provide reproducible estimates of the susceptibility of bacteria to antimicrobial compounds. The zone size provides an estimate of the susceptibility of bacteria to antimicrobial compounds. The zone size should be determined using a standard test method<span class="Sup">1,3,4</span>. This procedure uses paper disks impregnated with 30 mcg tetracycline to test the susceptibility of bacteria to tetracycline. The disk diffusion interpretive criteria are provided in Table 1.</p><p><span class="Bold"> </span></p><p><span class="Bold">A</span><span class="Bold">naerobic Techniques</span></p><p><span class="Bold"> </span></p><p>For anaerobic bacteria, the susceptibility to tetracycline can be determined by a standardized test method<span class="Sup">5</span>. The MIC values obtained should be interpreted according to the criteria provided in Table 1.</p><p class="First"><span class="Bold">T</span><span class="Bold">able 1: Susceptibility Test Interpretive Criteria for Tetracycline</span></p><p class="First"><span class="Bold">Bacteria<span class="Sup">a</span></span></p><p class="First"><span class="Bold">Minimal Inhibitory Concentration (mcg/mL)</span></p><p class="First"><span class="Bold">Zone</span></p><p><span class="Bold">Diameter</span></p><p><span class="Bold">(mm)</span></p><p class="First"><span class="Bold">Agar</span></p><p><span class="Bold">Dilution</span></p><p><span class="Bold">(mcg/mL)</span></p><p class="First"><span class="Bold">S</span></p><p class="First"><span class="Bold">I</span></p><p class="First"><span class="Bold">R</span></p><p class="First"><span class="Bold">S</span></p><p class="First"><span class="Bold">I</span></p><p class="First"><span class="Bold">R</span></p><p class="First"><span class="Bold">S</span></p><p class="First"><span class="Bold">I</span></p><p class="First"><span class="Bold">R</span></p><p class="First"><span class="Italics">Acinetobacter spp.</span></p><p class="First">&lt;4</p><p class="First">8</p><p class="First">&gt;16</p><p class="First">&gt;15</p><p class="First">12-14</p><p class="First">&lt;11</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First">Anaerobes</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First">&lt;4</p><p class="First">8</p><p class="First">&gt;16</p><p class="First"><span class="Italics">Bacillus</span><span class="Italics">anthracis<span class="Sup">a</span></span></p><p class="First">&lt;1</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First"><span class="Italics">Brucella</span> species<span class="Sup">a</span></p><p class="First">&lt;1</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First"><span class="Italics">Enterobacteriaceae</span></p><p class="First">&lt;4</p><p class="First">8</p><p class="First">&gt;16</p><p class="First">&gt;15</p><p class="First">12-14</p><p class="First">&lt;11</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First"><span class="Italics">Franciscella</span><span class="Italics">tularensis<span class="Sup">a</span></span></p><p class="First">&lt;4</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First"><span class="Italics">Haemophilus influenza<span class="Sup">e</span></span></p><p class="First">&lt;2</p><p class="First">4</p><p class="First">&gt;8</p><p class="First">&gt;29</p><p class="First">26-28</p><p class="First">&lt;25</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First"><span class="Italics">Mycoplasma pneumoniae</span></p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First"><span class="Bold">&lt;</span>2</p><p class="First">-</p><p class="First">-</p><p class="First"><span class="Italics">Neisseria gonorrhoeae<span class="Sup">b</span></span></p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First">&gt;38</p><p class="First">31-37</p><p class="First">&lt;30</p><p class="First">&lt;0.25</p><p class="First">0.5-1</p><p class="First">&gt;2</p><p class="First"><span class="Italics">Staphylococcus aureus</span></p><p class="First">&lt;4</p><p class="First">8</p><p class="First">&gt;16</p><p class="First">&gt;19</p><p class="First">15-18</p><p class="First">&lt;14</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First"><span class="Italics">Streptococcus pneumoniae</span></p><p class="First">&lt;1</p><p class="First">2</p><p class="First">&gt;4</p><p class="First">&gt;28</p><p class="First">25-27</p><p class="First">&lt;24</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First"><span class="Italics">Streptococcus pyogenes</span></p><p class="First">&lt;2</p><p class="First">4</p><p class="First">&gt;8</p><p class="First">&gt;23</p><p class="First">19-22</p><p class="First">&lt;18</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First"><span class="Italics">Vibrio cholerae</span></p><p class="First">&lt;4</p><p class="First">8</p><p class="First">&gt;16</p><p class="First">&gt;15</p><p class="First">12-14</p><p class="First">&lt;11</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First"><span class="Italics">Yersinia pestis</span></p><p class="First">&lt;4</p><p class="First">8</p><p class="First">&gt;16</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First">-</p><p class="First"><span class="Sup">a</span>The current absence of resistance isolates precludes defining any results other than “Susceptible”. If isolates yielding MIC results other than susceptible, they should be submitted to a reference laboratory for further testing.</p><p><span class="Sup">b</span>Gonococci with 30 mcg tetracycline disk zone diameters of less than 19 mm usually indicate a plasmid­mediated tetracycline resistant <span class="Italics">Neisseria gonorrhoeae</span> isolate. Resistance in these strains should be confirmed by a dilution test (MIC greater than or equal to 16 mcg/mL).</p><p>A report of <span class="Italics">Susceptible</span> (S) indicates that the antimicrobial is likely to inhibit growth of the pathogen if the antimicrobial compound reaches the concentrations usually achievable at the site of infection. A report of <span class="Italics">Intermediate</span> (I) indicates that the result should be considered equivocal, and, if the bacteria is not fully susceptible to alternative, clinically feasible drugs, the test should be repeated. This category implies possible clinical applicability in body sites where the drug is physiologically concentrated or in situations where high dosage of drug can be used. This category also provides a buffer zone that prevents small uncontrolled technical factors from causing major discrepancies in interpretation. A report of <span class="Italics">Resistant</span> (R) indicates that the antimicrobial is not likely to inhibit growth of the pathogen if the antimicrobial compound reaches the concentrations usually achievable at the infection site; other therapy should be selected.</p><p><span class="Bold">Q</span><span class="Bold">uality Control</span></p><p><span class="Bold"> </span></p><p>Standardized susceptibility test procedures require the use of laboratory controls to monitor and ensure the accuracy and precision of the supplies and reagents used in the assay, and the techniques of the individuals performing the test<span class="Sup">1,2,3,4,5,6,7</span>. Standard tetracycline powders should provide the following range of MIC values noted in Table 2. For the diffusion technique using the 30 mcg tetracycline disk the criteria noted in Table 2 should be achieved.</p><p class="First"><span class="Bold">Table 2: Acceptable Quality Control Ranges for Susceptibility Testing for Tetracycline</span></p><p class="First"><span class="Bold">QC Strain</span></p><p class="First"><span class="Bold">Minimal</span></p><p><span class="Bold">Inhibitory Concentration (mcg/mL)</span></p><p class="First"><span class="Bold">Zone</span></p><p><span class="Bold">Diameter</span></p><p><span class="Bold">(mm)</span></p><p class="First"><span class="Bold">Agar</span></p><p><span class="Bold">Dilution</span></p><p><span class="Bold">(mcg/mL)</span></p><p class="First"><span class="Italics">Enterococcus faecalis</span> ATCC 29212</p><p class="First">8 - 32</p><p class="First">-</p><p class="First">-</p><p class="First"><span class="Italics">Escherichia coli</span> ATCC 25922</p><p class="First">0.5 - 2</p><p class="First">18 - 25</p><p class="First">-</p><p class="First"><span class="Italics">Haemophilus influenzae</span> ATCC 49247</p><p class="First">4 - 32</p><p class="First">14 - 22</p><p class="First">-</p><p class="First"><span class="Italics">Mycoplasma pneumoniae</span> ATCC 29342</p><p class="First">0.06-0.5</p><p class="First">-</p><p class="First">0.06-0.5</p><p class="First"><span class="Italics">Neisseria gonorrhoeae</span> ATCC 49226</p><p class="First">-</p><p class="First">30 - 42</p><p class="First">0.25 - 1</p><p class="First"><span class="Italics">Staphylococcus aureus</span> ATCC 25923</p><p class="First">-</p><p class="First">24 - 30</p><p class="First">-</p><p class="First"><span class="Italics">Staphylococcus aureus</span> ATCC 29213</p><p class="First">0.12 - 1</p><p class="First">-</p><p class="First">-</p><p class="First"><span class="Italics">Streptococcus pneumoniae</span> ATCC 49619</p><p class="First">0.06 - 0.5</p><p class="First">27 - 31</p><p class="First">-</p><p class="First"><span class="Italics">Bacteroides fragilis</span> ATCC 25285</p><p class="First">-</p><p class="First">-</p><p class="First">0.12 - 0.5</p><p class="First"><span class="Italics">Bacteroides thetaiotaomicron</span> ATCC 29741</p><p class="First">-</p><p class="First">-</p><p class="First">8 - 32</p><h2>Indications and Usage for Sumycin Tablets</h2><p class="First">To reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs, tetracycline hydrochloride tablets should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.</p><p>Tetracycline hydrochloride tablets are indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below:</p><ul class="Disc">
<li>Upper respiratory tract infections caused by <span class="Italics">Streptococcus pyogenes</span>, <span class="Italics">Streptococcus pneumoniae</span> and <span class="Italics">Hemophilus influenzae</span>. Note: Tetracycline hydrochloride tablets should not be used for streptococcal disease unless the organism has been demonstrated to be susceptible.</li>
<li>Lower respiratory tract infections caused by <span class="Italics">Streptococcus pyogenes</span>, <span class="Italics">Streptococcus pneumoniae</span>, <span class="Italics">Mycoplasma pneumoniae</span> (Eaton agent, and <span class="Italics">Klebsiella sp</span>.)</li>
<li>Skin and soft tissue infections caused by <span class="Italics">Streptococcus pyogenes</span>, <span class="Italics">Staphylococcus aureaus</span>. (Tetracyclines are not the drugs of choice in the treatment of any type of staphylococcal infections.)</li>
<li>Infections caused by rickettsia including Rocky Mountain spotted fever, typhus group infections, Q fever, rickettsialpox.</li>
<li>Psittacosis caused by <span class="Italics">Chlamydophila psittaci</span>.</li>
<li>Infections caused by <span class="Italics">Chlamydia trachomatis</span> such as uncomplicated urethral, endocervical or rectal infections, inclusion conjunctivitis, trachoma, and lymphogranuloma venereum.</li>
<li>Granuloma inquinale caused by <span class="Italics">Klebsiella granulomatis</span>.</li>
<li>Relapsing fever caused by <span class="Italics">Borrelia sp.</span></li>
<li>Bartonellosis caused by <span class="Italics">Bartonella bacilliformis</span>.</li>
<li>Chancroid caused by <span class="Italics">Hemophilus ducreyi</span>.</li>
<li>Tularemia caused by <span class="Italics">Francisella tularensis</span>.</li>
<li>Plaque caused by <span class="Italics">Yersinia pestis</span>.</li>
<li>Cholera caused by <span class="Italics">Vibrio cholerae</span>.</li>
<li>Brucellosis caused by <span class="Italics">Brucella</span> species (tetracycline hydrochloride tablets may be used in conjunction with an aminoglycoside).</li>
<li>Infections due to <span class="Italics">Campylobacter fetus</span>.</li>
<li>As adjunctive therapy in intestinal amebiasis caused by <span class="Italics">Entamoeba histolytica</span>.</li>
<li>Urinary tract infections caused by susceptible strains of <span class="Italics">Escherichia coli</span>, <span class="Italics">Klebsiella</span>, etc.</li>
<li>Other infections caused by susceptible gram-negative organisms such as <span class="Italics">E. coli</span>, <span class="Italics">Enterobacter aerogenes</span>, <span class="Italics">Shigella sp., Acinetobacter sp</span>., <span class="Italics">Klebsiella sp</span>., and <span class="Italics">Bacteroides sp.</span></li>
<li>In severe acne, adjunctive therapy with tetracycline hydrochloride tablets may be useful.
<p class="First"> When penicillin is contraindicated, tetracyclines are alternative drugs in the treatment of the following infections:</p>
</li>
<li>Syphilis and yaws caused by <span class="Italics">Treponema pallidum and pertenue</span>, respectively,</li>
<li>Vincent’s infection caused by <span class="Italics">Fusobacterium fusiforme</span>,</li>
<li>Infections caused by <span class="Italics">Neisseria gonorrhoeae,</span></li>
<li>Anthrax caused by <span class="Italics">Bacillus anthracis,</span></li>
<li>Infections due to <span class="Italics">Listeria monocytogenes,</span></li>
<li>Actinomycosis caused by <span class="Italics">Actinomyces</span> species,</li>
<li>Infections due to <span class="Italics">Clostridium</span> species.</li>
</ul><p class="First"> When penicillin is contraindicated, tetracyclines are alternative drugs in the treatment of the following infections:</p><h2>Contraindications</h2><p class="First">This drug is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines.</p><h2>Warnings</h2><p class="First"><span class="Bold">T</span><span class="Bold">ooth Development</span></p><p><span class="Bold"> </span></p><p>The use of drugs of the tetracycline-class during tooth development (last half of pregnancy, infancy and childhood to the age of 8 years) may cause permanent discoloration of the teeth (yellow-gray-brown). This adverse reaction is more common during long-term use of the drugs but it has been observed following repeated short-term courses. Enamel hypoplasia has also been reported. Tetracycline drugs should not be used in this age group, except for anthrax, unless other drugs are not likely to be effective or are contraindicated.</p><p><span class="Bold"><span class="Italics">C</span></span><span class="Bold"><span class="Italics">l</span></span><span class="Bold"><span class="Italics">ostridium difficile</span></span> <span class="Bold">A</span><span class="Bold">ssociated Diarrhea</span></p><p><span class="Bold"> </span></p><p><span class="Italics">C</span><span class="Italics">l</span><span class="Italics">ostridium difficile</span> associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including tetracyclines, and may range in severity from mild diarrhea to fatal colitis. Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of <span class="Italics">C. difficile</span>.</p><p><span class="Italics">C. difficile</span> produces toxins A and B which contribute to the development of CDAD. Hypertoxin producing strains of <span class="Italics">C. difficile</span> cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy.  CDAD must be considered in all patients who present with diarrhea following antibacterial drugs. Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents.</p><p>If CDAD is suspected or confirmed, ongoing use of antibacterial drugs not directed against <span class="Italics">C. difficile</span> need to be discontinued. Appropriate fluid and electrolyte management, protein supplementation, antibacterial treatment of <span class="Italics">C. difficile,</span> and institute surgical evaluation clinically indicated.</p><p><span class="Bold">Photosensitivity</span></p><p><span class="Bold"> </span></p><p>Photosensitivity manifested by an exaggerated sunburn reaction has been observed in some individuals taking tetracyclines. Advise patients apt to be exposed to direct sunlight or ultraviolet lights that this reaction can occur with tetracycline drugs. Discontinue treatment at the first evidence of skin erythema.</p><p><span class="Bold">Intracranial Hypertension</span></p><p><span class="Bold"> </span></p><p>Intracranial hypertension (IH, pseudotumor cerebri) has been associated with the use of tetracyclines including Achromycin V. Clinical manifestations of IH include headache, blurred vision, diplopia, and vision loss; papilledema can be found on fundoscopy. Women of childbearing age who are overweight or have a history of IH are at greater risk for developing tetracycline associated IH. Concomitant use of isotretinoin and tetracycline should be avoided because isotretinoin, a systemic retinoid, is also known to cause pseudotumor cerebri.</p><p>Although IH typically resolve after discontinuation of treatment, the possibility for permanent visual loss exists. If visual disturbance occurs during treatment, prompt ophthalmologic evaluation is warranted. Since  intracranial  pressure  can  remain  elevated  for  weeks  after  drug  cessation  patients  should  be monitored until they stabilize.</p><p><span class="Bold">Skeletal Development</span></p><p><span class="Bold"> </span></p><p>All tetracyclines form a stable calcium complex in any bone forming tissue. A decrease in fibula growth rate has been observed in premature infants given oral tetracycline in doses of 25 mg/kg every six hours. This reaction was shown to be reversible when the drug was discontinued.</p><p>Results of animal studies indicate that tetracyclines cross the placenta, are found in fetal tissues and can have toxic effects on the developing fetus (often related to retardation of skeletal development). Evidence of embryotoxicity has also been noted in animals treated early in pregnancy. If this drug is used during pregnancy or if the patient becomes pregnant while taking this drug, apprise the patient of the potential hazard to the fetus. Tetracycline drugs should not be used during pregnancy unless absolutely necessary.</p><p><span class="Bold">Antianabolic Action</span></p><p><span class="Bold"> </span></p><p>The antianabolic action of the tetracyclines may cause an increase in BUN. While this is not a problem in those with normal renal function, in patients with significantly impaired renal function, higher serum levels of tetracycline may lead to azotemia, hyperphosphatemia and acidosis.</p><p><span class="Bold">Laboratory Monitoring for Long-Term Therapy</span></p><p><span class="Bold"> </span></p><p>In long-term therapy, perform periodic laboratory evaluation of organ systems, including hematopoietic, renal and hepatic studies. If renal impairment exists, even usual oral or parenteral doses may lead to excessive systemic accumulation of the drug and possible liver toxicity. Under such conditions, lower than usual total doses are indicated, and, if therapy is prolonged, serum level determinations of the drug may be advisable.</p><h2>Precautions</h2><h3>General</h3><p class="First">As with other antibacterials, use of this drug may result in overgrowth of nonsusceptible organisms, including fungi. If superinfection occurs, discontinue antibacterial and institute appropriate therapy.</p><p>Treat all infections due to Group A beta-hemolytic streptococci for at least ten days.</p><p>Perform incision and drainage or other surgical procedures in conjunction with antibacterial therapy, when indicated.</p><p>Prescribing  tetracycline  in  the  absence  of  proven  or  strongly  suspected  bacterial  infection  or  a prophylactic indication is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria.</p><h3>Information for Patients</h3><p class="First">Counsel patients that antibacterial drugs including tetracycline should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When tetracycline is prescribed to treat a bacterial infection, tell patients that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by tetracycline or other antibacterial drugs in the future.</p><h3>Laboratory Tests</h3><p class="First">In sexually transmitted infections, when coexistent syphilis is suspected, perform dark field examinations before treatment is started and the blood serology repeated monthly for at least four months.</p><h3>Drug Interactions</h3><p class="First">Since bacteriostatic drugs may interfere with the bactericidal action of penicillin, it is advisable to avoid giving tetracycline in conjunction with penicillin or other bactericidal antibacterials.</p><p>Because the tetracyclines have been shown to depress plasma prothrombin activity, patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage.</p><p>The concurrent use of tetracycline and methoxyflurane has been reported to result in fatal renal toxicity.</p><p>Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and preparations containing iron, zinc, or sodium bicarbonate.</p><p>Concurrent use of tetracycline may render oral contraceptives less effective.</p><h3>Carcinogenesis, Mutagenesis, Impairment of Fertility</h3><p class="First">Long-term animal studies are currently being conducted to determine whether tetracycline hydrochloride has carcinogenic potential.  Some related antibacterials (oxytetracycline, minocycline) have shown evidence of oncogenic activity in rats.</p><p>In two <span class="Italics">in vitro</span> mammalian cell assay systems (L 51784y mouse lymphoma and Chinese hamster lung cells), there was evidence of mutagenicity with tetracycline hydrochloride.</p><p>Tetracycline hydrochloride had no effect on fertility when administered in the diet to male and female rats at a daily intake of approximately 400 mg/kg/day, roughly 8 times the highest recommended human dose based on body surface area.</p><h3>Pregnancy</h3><p class="First">Teratogenic Effects</p><p><span class="Italics">Pregnancy Category D</span></p><p>(see <span class="Bold">WARNINGS</span>)</p><p>Nonteratogenic Effects</p><p>(see <span class="Bold">WARNINGS</span>)</p><p>Pregnant women with renal disease may be more prone to develop tetracycline-associated liver failure.</p><h3>Labor and Delivery</h3><p class="First">The effect of tetracyclines on labor and delivery is unknown.</p><h3>Nursing Mothers</h3><p class="First">Because of potential for serious adverse reaction in nursing infants from tetracyclines, a decision should be made whether to discontinue the drug, taking into account the importance of the drug to the mother (see <span class="Bold">WARNINGS</span>).</p><h3>Pediatric Use</h3><p class="First">See <span class="Bold">WARNINGS</span> and <span class="Bold">DOSAGE AND ADMINISTRATION. </span></p><h2>Adverse Reactions</h2><p class="First"><span class="Bold">Gastrointestinal:</span> anorexia, nausea, epigastric distress, vomiting, diarrhea, glossitis, black hairy tongue, dysphagia, enterocolitis, and inflammatory lesions (with <span class="Italics">Candida</span> overgrowth) in the anogenital region.</p><p>Esophagitis and esophageal ulceration have been reported in patients receiving particularly the capsule and also the tablet forms of tetracyclines.</p><p>Most of the patients were reported to have taken medication immediately before going to bed (see <span class="Bold">DOSAGE AND ADMINISTRATION</span>).</p><p><span class="Bold">Teeth:</span> permanent discoloration of teeth may be caused during tooth development. Enamel hypoplasia has been reported (see <span class="Bold">WARNINGS</span>).</p><p><span class="Bold">Skin:</span> maculopapular and erythrematous rashes. Exfoliative dermatitis has been reported. Onycholysis and discoloration of the nails have been reported. Photosensitivity is discussed in <span class="Bold">WARNINGS</span>.</p><p><span class="Bold">Renal Toxicity:</span> an increase in BUN has been reported and is dose related.</p><p><span class="Bold">Liver:</span> hepatotoxicity and liver failure have been observed in patients receiving tetracycline and in tetracycline-treated patients with renal impairment.</p><p><span class="Bold">Hypersensitivity Reactions:</span> urticaria, angioneurotic edema, anaphylaxis, anaphylactoid purpura, pericarditis, exacerbation of systemic lupus erythematosus, and serum sickness-like reactions, as fever, rash, and arthralgia.</p><p><span class="Bold">Blood:</span> hemolytic anemia, thrombocytopenia, thrombocytopenic purpura, neutropenia and eosinophilia have been reported.</p><p>When  given  over  prolonged  periods,  tetracyclines  have  been  reported  to  produce  brown-black microscopic discoloration of thyroid glands. No abnormalities of thyroid function studies are known to occur.</p><h2>Overdosage</h2><p class="First">In case of overdosage, discontinue medication, treat symptomatically and institute supportive measures. Tetracycline is not dialyzable.</p><h2>Sumycin Tablets Dosage and Administration</h2><p class="First">Adults: Usual daily dose, 1 gram as 500 mg twice a day or 250 mg four times a day. Higher doses such as 500 mg four times a day may be required for severe infections or for those infections which do not respond to the smaller doses.</p><p>For pediatric patients above eight years of age: Usual daily dose, 10 mg/lb to 20 mg/lb (25 mg/kg to 50 mg/kg) body weight divided in four equal doses.</p><p>Administration of adequate amounts of fluid with the tablet formulation of tetracycline is recommended to wash down the drug and reduce the risk of esophageal irritation and ulceration (see <span class="Bold">ADVERSE REACTIONS</span>).</p><p>Absorption of tetracycline is impaired by antacids containing aluminum, calcium or magnesium and preparations containing iron, zinc or sodium bicarbonate. Food and some dairy products also interfere with absorption.</p><p>When used in streptococcal infections, therapy should be continued for 10 days.</p><p>For treatment of brucellosis, 500 mg tetracycline hydrochloride tablets four times a day for three weeks accompanied by streptomycin, 1 gram intramuscularly twice daily the first week and once daily the second week.</p><p>For the treatment of syphilis in patients allergic to penicillin, the following dosage of tetracycline hydrochloride tablets is recommended: early syphilis (less than one year’s duration), 500 mg four times a day for 15 days. Syphilis of more than one year’s duration (except neurosyphilis), 500 mg four times a day for 30 days.</p><p>For treatment of gonorrhea, the recommended dose is 500 mg by mouth four times a day for seven days.</p><p>Uncomplicated urethral, endocervical or rectal infections in adults caused by <span class="Italics">Chlamydiatrachomatis</span>: 500 mg, by mouth, four times a day for at least seven days.</p><p>In cases of moderate to severe acne which, in the judgement of the clinician, require long-term treatment, the recommended initial dosage is 1 gram daily in divided doses. When improvement is noted, reduce dosage gradually to maintenance levels ranging from 125 mg to 500 mg daily. In some patients it may be possible to maintain adequate remission of lesions with alternate day or intermittent therapy. Tetracycline hydrochloride tablets therapy of acne should augment the other standard measures known to be of value. Duration of long-term treatment which can safely be recommended has not been established (see <span class="Bold">WARNINGS</span> and <span class="Bold">Carcinogenesis, Mutagenesis, Impairment of Fertility</span>).</p><h3>Use in Specific Population</h3><p class="First">In  patients  with  renal  impairment  (see  <span class="Bold">WARNINGS</span>):  decrease  total  dosage  by  reduction  of recommended individual doses and/or by extending time intervals between doses.</p><h2>How is Sumycin Tablets Supplied</h2><p class="First">Tetracycline Hydrochloride Tablets, USP are available as:</p><p>250 mg: Light pink, ovaloid, coated tablet debossed with “732” on one side and plain on the other side.</p><p>Available in bottles of:</p><p>Bottles of 100            NDC 49884-732-01</p><p>Bottles of 1,000         NDC 49884-732-10</p><p>500 mg: Pink, ovaloid, coated tablet debossed with “733” on one side and plain on the other side.</p><p>Available in bottles of:</p><p>Bottles of 100           NDC 49884-733-01</p><p>Bottles of 500           NDC 49884-733-05</p><p>Dispense in a tight, light-resistant containers as defined in the USP. Use child-resistant closure (as required).</p><p>Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].</p><p>Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.</p><h2>ANIMAL PHARMACOLOGY AND ANIMAL TOXICOLOGY</h2><p class="First">Hyperpigmentation of the thyroid has been produced by members of the tetracycline class in the following species: in rats by oxytetracycline, doxycycline, minocycline, tetracycline PO<span class="Sub">4</span> and methacycline; in minipigs by doxycycline, minocycline, tetracycline PO<span class="Sub">4</span> and methacycline; in dogs by doxycycline and minocycline; in monkeys by minocycline.</p><p>Minocycline, tetracycline PO4, methacycline, doxycycline, tetracycline base, oxytetracycline HCl and tetracycline HCl were goitrogenic in rats fed a low iodine diet. This goitrogenic effect was accomplished by high radioactive iodine uptake. Administration of minocycline also produced a large goiter with high radioiodine uptake in rats fed a relatively high iodine diet.</p><p>Treatment of various animal species with this class of drugs has also resulted in the induction of thyroid hyperplasia in the following: in rats and dogs (minocycline), in chickens (chlortetracycline) and in rats and mice (oxytetracycline). Adrenal gland hyperplasia has been observed in goats and rats treated with oxytetracycline.</p><h2>REFERENCES</h2><p class="First">Rx only</p><p>Dist. by:</p><p><span class="Bold">Par Pharmaceutical</span></p><p>Chestnut Ridge, NY 10977 U.S.A.</p><p>Mfg. by:</p><p><span class="Bold">Par Formulations Private Limited,</span></p><p>9/215, Pudupakkam, Kelambakkam - 603 103.</p><p>Made in India</p><p>Mfg. Lic. No.: TN00002121</p><p>OS732-01-74-01</p><p>Issued: 06/2017</p><h2>PACKAGE LABEL PRINCIPAL DISPLAY PANEL</h2><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>What are the best antibiotics for pneumonia?</li>
<li>How long do antibiotics take to work?</li>
</ul><h2>More about Sumycin (tetracycline)</h2><ul class="more-resources-list more-resources-list-general">
<li>Side Effects</li>
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>Drug class: tetracyclines</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li>Tetracycline &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(AHFS Monograph)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Acne</li>
<li>Bacterial Infection</li>
<li>Bladder Infection</li>
<li>Bronchitis</li>
<li data-more-config-id="list-data-resources-conditions">... +24 more</li>
</ul><p class="ddc-disclaimer-link">Medical Disclaimer</p></body></html>